New Project Funded: How Does LRRK2 Activity Affect Inflammatory Signaling in Parkinson’s Disease?
Tuesday, 1 August 2017Study Rationale: Differences in the leucine-rich repeat kinase 2 (LRRK2) gene can increase the risk of developing Parkinson’s disease (PD), and there is an abundance of the LRRK2 protein in blood immune cells that regulate inflammation. This project will determine…